IRIX (IRIDEX) E10: $-0.83 (As of Mar. 2026)


IRIX IRIDEX Corp IRIX
66 GF Score
Price $1.19
GF Value $1.70
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is IRIDEX E10?

IRIDEX IRIX +1.28% 66 E10 is $-0.83 as of Mar. 2026. GuruFocus rates IRIX with a GF Score™ of 66/100 and a GF Value™ of $1.70 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

IRIDEX's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.83 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -21.60% per year. During the past 5 years, the average E10 Growth Rate was -24.90% per year. During the past 10 years, the average E10 Growth Rate was -18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of IRIDEX was 29.80% per year. The lowest was -58.70% per year. And the median was 2.25% per year.

As of today (2026-06-25), IRIDEX's current stock price is $1.19. IRIDEX's E10 for the quarter that ended in Mar. 2026 was $-0.83. IRIDEX's Shiller PE Ratio of today is .


IRIDEX  (NAS:IRIX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


IRIDEX E10 Related Terms


IRIDEX E10 Historical Data

* Premium members only.

The historical data trend for IRIDEX's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IRIDEX E10 Chart

IRIDEX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -0.45 -0.56 -0.76 -0.81

IRIDEX Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.78 -0.78 -0.80 -0.81 -0.83

IRIX vs ICCM, ADGM, CSDX: E10 Comparison

For the Medical Devices subindustry, IRIDEX's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRIDEX Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IRIDEX's Shiller PE Ratio falls into.


IRIX
66GF Score
IRIDEX Corp IRIX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IRIDEX E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IRIDEX's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.03/330.2130*330.2130
=-0.030

Current CPI (Mar. 2026) = 330.2130.

IRIDEX Quarterly Data

per share eps CPI Adj_EPS
201606 -0.030 241.018 -0.041
201609 -0.070 241.428 -0.096
201612 -1.040 241.432 -1.422
201703 -0.160 243.801 -0.217
201706 -0.240 244.955 -0.324
201709 -0.270 246.819 -0.361
201712 -0.440 246.524 -0.589
201803 -0.310 249.554 -0.410
201806 -0.280 251.989 -0.367
201809 -0.260 252.439 -0.340
201812 -0.210 251.233 -0.276
201903 -0.220 254.202 -0.286
201906 -0.180 256.143 -0.232
201909 -0.130 256.759 -0.167
201912 -0.110 256.974 -0.141
202003 -0.120 258.115 -0.154
202006 -0.200 257.797 -0.256
202009 -0.120 260.280 -0.152
202012 -0.010 260.474 -0.013
202103 -0.140 264.877 -0.175
202106 0.090 271.696 0.109
202109 -0.140 274.310 -0.169
202112 -0.150 278.802 -0.178
202203 -0.150 287.504 -0.172
202206 -0.140 296.311 -0.156
202209 -0.110 296.808 -0.122
202212 -0.070 296.797 -0.078
202303 -0.130 301.836 -0.142
202306 -0.170 305.109 -0.184
202309 -0.110 307.789 -0.118
202312 -0.180 306.746 -0.194
202403 -0.210 312.332 -0.222
202406 -0.160 314.175 -0.168
202409 -0.120 315.301 -0.126
202412 -0.050 315.605 -0.052
202503 -0.100 319.799 -0.103
202506 -0.060 322.561 -0.061
202509 -0.090 324.800 -0.091
202512 -0.010 324.054 -0.010
202603 -0.030 330.213 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.83 mean?
IRIDEX (IRIX) has a E10 of $-0.83 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on IRIDEX and its competitors.
Is IRIDEX's E10 too high?
IRIDEX's current E10 is $-0.83. Overall, IRIDEX has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IRIDEX's E10 compare to ICCM and ADGM?
IRIDEX's E10 of $-0.83 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on IRIDEX and its competitors. IRIDEX's current E10 is $-0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRIDEX stock overvalued right now?
Based on GuruFocus' analysis, IRIDEX (IRIX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.70, compared to a current price of $1.19 — trading 30% below its estimated fair value. The current E10 is $-0.83. IRIDEX's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For IRIDEX (IRIX), the current E10 is $-0.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IRIDEX (IRIX) Overvalued in 2026?

Based on GuruFocus' analysis, IRIDEX stock appears to be undervalued. The current stock price of $1.19 is trading 30% below its estimated GF Value™ of $1.70. GuruFocus considers IRIDEX to be Possible Value Trap.

Key valuation signals for IRIX:

  • E10: $-0.83
  • GF Value™: $1.70 vs. price of $1.19 (30% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the IRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IRIDEX Business Description

Address 1212 Terra Bella Avenue, Mountain View, CA, USA, 94043
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
66GF Score

Get the complete analysis for IRIX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$1.70
GF Value